Emily Burke at Biotech Primer examines Alzheimer’s disease (AD) and how it ranks as one of the toughest nuts to crack within drug discovery and development. Current treatments merely manage symptoms, so finding a better solution becomes more and more urgent as the aging population grows. With more hard work and investment, perhaps one of the many introduced in this article will lead to a cure – or perhaps the winning therapy may include a combination of these approaches.

[wonderplugin_pdf src=”https://www.biopharmaceuticalmedia.com/wp-content/uploads/2019/04/Alzheimers-disease_the-way-forward.pdf” width=”100%” height=”900px” style=”border:0;”]